Description

This issue of Vital Signs, released on November 16, 2009, provides a strategic overview of the potential impact of the medical device tax component in U.S. Healthcare reform proposals. Additionally, a company spotlight is provided for Xoft, Inc., a leading innovator and developer of electronic brachytherapy systems. Reimbursement and regulatory news from the FDA is also provided for the week of November 2, 2009.